References
- Multiple sclerosis by the numbers: facts, statistics and you. 2015. Available at: http://www.healthline.com/health/multiple-sclerosis/facts-statistics-infographic [Last accessed 10 January 2017]
- Jelinek GA, Marck CH, Weiland TJ, et al. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis. BMC Neurol 2015;15:132
- Bjornevik K, Riise T, Casetta I, et al. Sun exposure and multiple sclerosis risk in Norway and Italy: the EnvIMS study. Mult Scler 2014;20:1042-9
- Zivadinov R, Treu CN, Weinstock-Guttman B, et al. Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis. J Neurol Neurosurg Psychiatry 2013;84:1075-81
- Zhang P, Wang R, Li Z, et al. The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case–control and cohort studies. PeerJ 2016;4:e1797
- O’Gorman CM, Broadley SA. Smoking increases the risk of progression in multiple sclerosis: a cohort study in Queensland, Australia. J Neurol Sci 2016;370:219-23
- Poorolajal J, Bahrami M, Karami M, Hooshmand E. Effect of smoking on multiple sclerosis: a meta-analysis. J Public Health (Oxf) 2016:1?9, doi:10.1093/pubmed/fdw030
- Backhaus I, Mannocci A, Lemmens PH, La Torre G. Smoking as a risk factor for developing multiple sclerosis: a meta-analysis of observational studies. La Clinica Terapeutica 2016;167:82-92
- Abdollahpour I, Nedjat S, Sahraian MA, et al. Waterpipe smoking associated with multiple sclerosis: A population-based incident case–control study. Mult Scler 2016:1-8, doi: 10.1177/1352458516677867
- Fainardi E, Castellazzi M, Tamborino C, et al. Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms. J Neurovirology 2009;15:425-33
- Fainardi E, Castellazzi M, Seraceni S, et al. Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res 2008;5:60-70
- Ha SU. Re: “Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case–control study”. Am J Epidemiol 2012;175:728; author reply -9
- Berlanga-Taylor AJ, Disanto G, Ramagopalan SV. Re: “Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study”. Am J Epidemiol 2012;175:727-8; author reply 8-9
- Norgaard M, Nielsen RB, Jacobsen JB, et al. Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case–control study. Am J Epidemiol 2011;174:945-8
- Alonso A, Jick SS, Jick H, Hernan MA. Antibiotic use and risk of multiple sclerosis. Am J Epidemiol 2006;163:997-1002
- Alonso A, Jick SS, Hernan MA. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 2006;66:572-5
- Ashtari F, Jamshidi F, Shoormasti RS, et al. Cow’s milk allergy in multiple sclerosis patients. J Res Med Sci 2013;18:S62-S5
- Ramagopalan SV, Dyment DA, Guimond C, et al. Childhood cow’s milk allergy and the risk of multiple sclerosis: a population based study. J Neurol Sci 2010;291:86-8
- Sahraian MA, Jafarian S, Sheikhbahaei S, Safavi F. Respiratory tract rather than cutaneous atopic allergy inversely associate with multiple sclerosis: a case–control study. Clin Neurol Neurosurg 2013;115:2099-102
- Pedotti R, Farinotti M, Falcone C, et al. Allergy and multiple sclerosis: a population-based case–control study. Mult Scler 2009;15:899-906
- Alonso A, Hernan MA, Ascherio A. Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis. Acta Neurol Scand 2008;117:15-20
- Karimi P, Modarresi SZ, Sahraian MA, et al. The relation of multiple sclerosis with allergy and atopy: a case control study. Iranian J Allergy Asthma Immunol 2013;12:182-9
- Kraemer HC, Kiernan M, Essex M, Kupfer DJ. How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychol 2008;27:S101-S8
- Ambulatory Health Care Data. 2016. Available at: https://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm [Last accessed 21 March 2017]
- Luger EO, Wegmann M, Achatz G, et al. Allergy for a lifetime? Allergol Int 2010;59:1-8
- Aiello AE, Coulborn RM, Perez V, Larson EL. Effect of hand hygiene on infectious disease risk in the community setting: a meta-analysis. Am J Publ Health 2008;98:1372-81
- ICD-9-CM to ICD-10 Common Codes for Allergy. QuestDiagnostics, 2015. Available at: https://www.questdiagnostics.com/dms/Documents/Other/ICD-10-CPT-2012/37778-v2-ICD-9-10-CM-codes-for-Allergy-MI3857-42722/37778-v2-ICD-9-10-CM%20codes%20for%20Allergy-MI3857-042715.pdf [Last accessed 18 January 2017]
- Hoyle RH, Gottfredson NC. Sample size considerations in prevention research applications of multilevel modeling and structural equation modeling. Prev Sci 2015;16:987-96
- Sideridis G, Simos P, Papanicolaou A, Fletcher J. Using structural equation modeling to assess functional connectivity in the brain: power and sample size considerations. Educ Psychol Meas 2014;74:733-58
- Wolf EJ, Harrington KM, Clark SL, Miller MW. Sample size requirements for structural equation models: an evaluation of power, bias, and solution propriety. Educ Psychol Meas 2013;76:913-34
- Nussbeck FW, Eid M, Lischetzke T. Analysing multitrait-multimethod data with structural equation models for ordinal variables applying the WLSMV estimator: what sample size is needed for valid results? Br J Math Stat Psychol 2006;59:195-213
- Match. Mayo Clinic, 2004. Available at: http://www.mayo.edu/research/documents/matchsas/doc-10027556 [Last accessed 21 March 2017]
- Westland JC. Structural Equation Modeling: From Paths to Networks. New York: Springer, 2015
- Ngoc PL, Gold DR, Tzianabos AO, et al. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 2005;5:161-6
- Oreja-Guevara C, Ramos-Cejudo J, Aroeira LS, et al. TH1/TH2 cytokine profile in relapsing–remitting multiple sclerosis patients treated with glatiramer acetate or natalizumab. BMC Neurol 2012;12:95
- Fletcher JM, Lalor SJ, Sweeney CM, et al. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 2010;162:1-11
- Pender MP, Csurhes PA, Burrows JM, Burrows SR. Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis. Clin Translational Immunol 2017;6:e126
- Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 2006;12:397-411
- Alter M, Zhang ZX, Davanipour Z, et al. Multiple sclerosis and childhood infections. Neurology 1986;36:1386-9
- Jaruvongvanich V, Sanguankeo A, Jaruvongvanich S, Upala S. Association between Helicobacter pylori infection and multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord 2016;7:92-7
- Ockinger J, Hagemann-Jensen M, Kullberg S, et al. T-cell activation and HLA-regulated response to smoking in the deep airways of patients with multiple sclerosis. Clin Immunol 2016;169:114-20
- Ramanujam R, Hedstrom AK, Manouchehrinia A, et al. Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol 2015;72:1117-23
- Wang Z, Sadovnick AD, Traboulsee AL, et al. Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron 2016;90:948-54
- Xiao D, Ye X, Zhang N, et al. A meta-analysis of interaction between Epstein–Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis. Sci Rep 2015;5:18083